Home / PMCB : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis Similar

AI Analysis

How does PMCB make money? Does PMCB have pricing power? What's the Earnings Whisper? Will PMCB profit more as the business scales? What is PMCB's management track record? Is PMCB's current price justified?

PharmaCyte Biotech, Inc.

$0.41 -$0.33 (-44.19%)

NASDAQ · 14 Sep 2026 16:30 UTC

Previous Close

$0.45

Day Range

$0.35$0.45

Year Range

$0.35$1.51

Market Cap

4.42M

AVG Volume

163.78K

Trailing/Forward PE

-0.13/-

PEG ratio

Dividend Yield

Next Earnings Date

Primary Exchange

NASDAQ

Net Income (USD)

PMCB Net Income (USD) by year
Period	Net Income (USD)
2026	-19.42M
2025	30.66M
2024	334K
2023	-3.09M
2022	-4.19M
2021	-3.55M
2020	-3.83M
2019	-4.07M
2018	-6.83M
2017	-4.44M

Operating Income (USD)

PMCB Operating Income (USD) by year
Period	Operating Income (USD)
2026	-6.85M
2025	-4.38M
2024	-8.52M
2023	-6.46M
2022	-4.39M
2021	-3.62M
2020	-3.83M
2019	-4.1M
2018	-6.98M
2017	-4.44M

EBITDA (USD)

PMCB EBITDA (USD) by year
Period	EBITDA (USD)
2026	-5.3M
2025	-4.38M
2024	-4.01M
2023	-4.32M
2022	-1.35M
2021	73.04K
2020	-2.2M
2019	-4.1M
2018	-6.98M
2017	-4.44M

Cash Flows (USD)

PMCB Cash Flows (USD) by year
Period	Cash Flows (USD)
2026	-5.15M
2025	-2.98M
2024	-2.15M
2023	-3.79M
2022	-4.12M
2021	-3.33M
2020	-2.34M
2019	-2.88M
2018	-5.08M
2017	-3.34M

EPS (USD)

PMCB EPS (USD) by year
Period	EPS (USD)
2026	-3.1
2025	3.11
2024	-1.82
2023	-0.6
2022	-1.25
2021	-2.52
2020	-4.23
2019	-5.49
2018	-10.51
2017	-7.79

Expenses (USD)

PMCB Expenses (USD) by year
Period	Expenses (USD)
2026	5.3M
2025	5.28M
2024	6.52M
2023	6.46M
2022	4.39M
2021	3.62M
2020	3.83M
2019	4.1M
2018	6.98M
2017	4.44M

Cash & Debt (USD)

PMCB Cash & Debt (USD) by year
Period	Cash & Debt (USD)
2026	37.08M
2025	15.54M
2024	50.18M
2023	68.04M
2022	85.4M
2021	2.2M
2020	894.86K
2019	515.25K
2018	1.06M
2017	3.46M

Debt ratios

PMCB Debt ratios by year
Period	Debt ratios
2026	2.06
2025	1.11
2024	5.23
2023	8.72
2022	11.26
2021	0.17
2020	0.05
2019	0.02

Return on Capital

PMCB Return on Capital by year
Period	Return on Capital
2026	-55.53%
2025	59.08%
2024	0.85%
2023	-4.25%
2022	-4.66%
2021	-53.16%
2020	-75.18%
2019	-80.7%
2018	-118.36%
2017	-54.95%

Shares Outstanding

PMCB Shares Outstanding by year
Period	Shares Outstanding
2026	9.61M
2025	6.85M
2024	8.04M
2023	16.79M
2022	15.52M
2021	1.56M
2020	1.12M
2019	807.27K
2018	666.98K
2017	590.04K

Book Value Per Share (USD)

PMCB Book Value Per Share (USD) by year
Period	Book Value Per Share (USD)
2026	3.64
2025	7.57
2024	4.92
2023	4.33
2022	5.79
2021	4.28
2020	4.54
2019	6.24
2018	8.65
2017	13.71

Total Assets (USD)

PMCB Total Assets (USD) by year
Period	Total Assets (USD)
2026	46.75M
2025	55.17M
2024	59.9M
2023	73.28M
2022	90.62M
2021	7.4M
2020	6.17M
2019	5.78M
2018	6.41M
2017	8.67M

Employee Count

PMCB Employee Count by year
Period	Employee Count
2026	2
2025	2
2024	2
2023	2
2022	4
2021	4
2020	4
2019	4
2018	4
2017	4

PE Ratio

PMCB PE Ratio by year
Period	PE Ratio
Sep 25	0.23
Sep 25	0.21
Aug 25	0.21
Aug 25	0.22
Aug 25	0.2
Aug 25	0.29
Aug 25	0.34
Jul 25	0.33
Jul 25	0.35
Jul 25	0.37
Jul 25	0.38
Jun 25	0.35
Jun 25	0.36
Jun 25	0.35
Jun 25	0.35
May 25	0.35
May 25	0.36
May 25	0.36
May 25	0.38
May 25	0.42
Apr 25	0.42
Apr 25	0.41
Apr 25	0.42
Apr 25	0.43
Mar 25	0.45
Mar 25	0.54
Mar 25	0.48
Mar 25	0.54
Feb 25	0.54
Feb 25	0.54
Feb 25	0.5
Feb 25	0.46
Jan 25	0.49
Jan 25	0.5
Jan 25	0.52
Jan 25	0.47
Jan 25	0.5
Dec 24	0.48
Dec 24	0.5
Dec 24	0.53
Dec 24	0.48
Nov 24	0.5
Nov 24	0.5
Nov 24	0.48
Nov 24	0.53
Nov 24	0.53
Oct 24	0.53
Oct 24	0.5
Oct 24	0.51
Oct 24	0.52
Sep 24	0.54
Sep 24	0.47
Sep 24	45.73
Sep 24	38.26
Aug 24	36.82
Aug 24	39.95
Aug 24	45.24

Free Cash Flow Yield

PMCB Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-119.12%
Sep 26	-110.23%
Aug 26	-104.13%
Aug 26	-100.61%
Aug 26	-97.32%
Aug 26	-90.88%
Jul 26	-93.1%
Jul 26	-179.97%
Jul 26	-170.62%
Jul 26	-155.06%
Jul 26	-151.05%
Jun 26	-140.32%
Jun 26	-150.46%
Jun 26	-141.92%
Jun 26	-154.29%
May 26	-129.44%
May 26	-133.34%
May 26	-134.27%
May 26	-142.9%
May 26	-142.99%
Apr 26	-149.53%
Apr 26	-148.23%
Apr 26	-165.37%
Apr 26	-156.53%
Mar 26	-152.55%
Mar 26	-157.26%
Mar 26	-109.44%
Mar 26	-100.31%
Feb 26	-109.45%
Feb 26	-107.52%
Feb 26	-110.98%
Feb 26	-101.91%
Jan 26	-92.23%
Jan 26	-80.53%
Jan 26	-84.86%
Jan 26	-85.69%
Jan 26	-102.35%
Dec 25	-106.37%
Dec 25	-88.08%
Dec 25	-66.35%
Dec 25	-55.48%
Nov 25	-87.49%
Nov 25	-104.13%
Nov 25	-86%
Nov 25	-79.44%
Oct 25	-72.78%
Oct 25	-69.28%
Oct 25	-69.83%
Oct 25	-67.68%
Oct 25	-65.08%
Sep 25	-69.78%
Sep 25	-69.06%
Sep 25	-41.78%
Sep 25	-46.17%
Aug 25	-46.27%
Aug 25	-44.79%
Aug 25	-48.28%
Aug 25	-39.31%
Aug 25	-32.63%
Jul 25	-34.17%
Jul 25	-31.68%
Jul 25	-30.21%
Jul 25	-29.39%
Jun 25	-31.68%
Jun 25	-30.78%
Jun 25	-32.3%
Jun 25	-31.99%
May 25	-31.68%
May 25	-31.07%
May 25	-30.78%
May 25	-29.39%
May 25	-26.96%
Apr 25	-26.74%
Apr 25	-27.42%
Apr 25	-26.53%
Apr 25	-26.31%
Mar 25	-24.72%
Mar 25	-20.65%
Mar 25	-17.67%
Mar 25	-15.68%
Feb 25	-15.86%
Feb 25	-15.86%
Feb 25	-17.13%
Feb 25	-18.74%
Jan 25	-17.45%
Jan 25	-17.13%
Jan 25	-16.52%
Jan 25	-18.37%
Jan 25	-17.02%
Dec 24	-17.78%
Dec 24	-17.02%
Dec 24	-16.23%
Dec 24	-22.23%
Nov 24	-21.32%
Nov 24	-21.44%
Nov 24	-22.23%
Nov 24	-20.25%
Nov 24	-19.92%
Oct 24	-20.25%
Oct 24	-21.32%

EV/EBITDA

PMCB EV/EBITDA by year
Period	EV/EBITDA
Jul 22	-237.34
Jul 22	-241.85
Jul 22	-249.37
Jul 22	-264.4
Jun 22	-273.42
Jun 22	-279.44
Jun 22	-285.45
Jun 22	-271.92
May 22	-265.91
May 22	-267.41
May 22	-274.93
May 22	-267.41
Apr 22	-250.87
Apr 22	-277.93
Apr 22	-268.91
Apr 22	-264.4
Apr 22	-259.89
Mar 22	-243.36
Mar 22	-244.86
Mar 22	-498.46
Mar 22	-484.42
Feb 22	-519.54
Feb 22	-526.56
Feb 22	-505.49
Feb 22	-510.76
Jan 22	-512.51
Jan 22	-519.54
Jan 22	-454.56
Jan 22	-444.03
Dec 21	-440.52
Dec 21	-407.15
Dec 21	-445.78
Dec 21	41.58
Dec 21	39.41
Nov 21	41.14
Nov 21	43.53
Nov 21	48.3
Nov 21	50.47
Oct 21	48.08
Oct 21	46.56
Oct 21	52.85
Oct 21	56.11
Oct 21	55.89
Sep 21	58.49
Sep 21	65
Sep 21	46.48
Sep 21	42.42
Aug 21	44.34
Aug 21	44.13
Aug 21	39.65

Price to Book

PMCB Price to Book by year
Period	Price to Book
Sep 26	0.12
Sep 26	0.13
Aug 26	0.14
Aug 26	0.15
Aug 26	0.15
Aug 26	0.16
Jul 26	0.16
Jul 26	0.07
Jul 26	0.07
Jul 26	0.08
Jul 26	0.08
Jun 26	0.09
Jun 26	0.08
Jun 26	0.09
Jun 26	0.08
May 26	0.09
May 26	0.09
May 26	0.09
May 26	0.09
May 26	0.09
Apr 26	0.08
Apr 26	0.08
Apr 26	0.07
Apr 26	0.08
Mar 26	0.08
Mar 26	0.08
Mar 26	0.11
Mar 26	0.12
Feb 26	0.11
Feb 26	0.12
Feb 26	0.11
Feb 26	0.12
Jan 26	0.13
Jan 26	0.15
Jan 26	0.15
Jan 26	0.14
Jan 26	0.12
Dec 25	0.12
Dec 25	0.14
Dec 25	0.16
Dec 25	0.19
Nov 25	0.12
Nov 25	0.1
Nov 25	0.12
Nov 25	0.13
Oct 25	0.14
Oct 25	0.15
Oct 25	0.15
Oct 25	0.16
Oct 25	0.16
Sep 25	0.15
Sep 25	0.15
Sep 25	0.14
Sep 25	0.12
Aug 25	0.12
Aug 25	0.13
Aug 25	0.12
Aug 25	0.14
Aug 25	0.17
Jul 25	0.17
Jul 25	0.18
Jul 25	0.19
Jul 25	0.19
Jun 25	0.18
Jun 25	0.18
Jun 25	0.17
Jun 25	0.18
May 25	0.18
May 25	0.18
May 25	0.18
May 25	0.19
May 25	0.21
Apr 25	0.21
Apr 25	0.21
Apr 25	0.21
Apr 25	0.21
Mar 25	0.23
Mar 25	0.27
Mar 25	0.25
Mar 25	0.28
Feb 25	0.28
Feb 25	0.28
Feb 25	0.26
Feb 25	0.24
Jan 25	0.26
Jan 25	0.26
Jan 25	0.27
Jan 25	0.24
Jan 25	0.26
Dec 24	0.25
Dec 24	0.26
Dec 24	0.27
Dec 24	0.24
Nov 24	0.25
Nov 24	0.25
Nov 24	0.24
Nov 24	0.27
Nov 24	0.27
Oct 24	0.27
Oct 24	0.25

No video analysis for this stock yet. Request one from our team.

AI Analysis

PharmaCyte Biotech, Inc.

Video analysis: PMCB

Similar companies